Confront your periodontal (gum) disease

Gum disease is caused by bacteria below the gumline.

And it’s the #1 cause of adult tooth loss in the United States.

Even so, many people are tempted to ignore their dental professional's advice to treat gum disease in its early stages.

You have a choice. Do more now, or allow the disease to progress further. Left untreated, gum disease may lead to more serious problems that may require painful and expensive surgery.

In combination with scaling and root planing (SRP), your dentist can apply ARESTIN^® to help treat your moderate to severe gum disease.

Image of inflammation on gums, plaque on tooth within periodontal pocket

CAUSES See how plaque buildup can cause a bacterial infection and lead to gum disease.		SYMPTOMS Learn about the most common symptoms of gum disease and why they happen.		STAGES Gum disease has several stages that can lead to disease progression.		TREATMENT Many dental professionals recommend ARESTIN^® with SRP to treat gum disease.
Learn more about gum infections and bacteria		Learn more about common symptoms		Learn more about the stages		Learn more about treatment

Learn how ARESTIN^® helpsContinue

While ARESTIN^® has been demonstrated along with SRP to reduce pocket depth and bacteria in patients with periodontal disease, it has not been proven in clinical trials to reduce tooth loss.

INDICATION
ARESTIN^® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN^® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION
ARESTIN^® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face, and pruritus have been reported with the use of ARESTIN^®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome, and pain.

Please see full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ARESTIN^® is a registered trademark of OraPharma, Inc.

1-866-ARESTIN (1-866-273-7846)

This site is published by OraPharma, Inc., which is solely responsible for its contents. It is intended for visitors from the United States.